| Entry |
|
|---|
| Name |
Fotemustine (INN/BAN);
Muphoran (TN) |
|---|
| Formula |
C9H19ClN3O5P
|
|---|
| Exact mass |
315.0751
|
|---|
| Mol weight |
315.69
|
|---|
| Structure |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Comment |
Nitrosourea
|
|---|
| Target |
DNA |
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AD Nitrosoureas
L01AD05 Fotemustine
D07255 Fotemustine (INN/BAN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01724 Nitrosourea
D07255 Fotemustine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 X Cl 24.7100 -15.6100
2 C1b C 23.5200 -16.3100
3 C1b C 22.2600 -15.6100
4 N1c N 21.0700 -16.3100
5 C5a C 19.8800 -15.6100
6 N1b N 18.6200 -16.3100
7 C1c C 17.4300 -15.6100
8 P1b P 16.2400 -16.3100
9 O3b O 16.9400 -17.5000
10 O2b O 14.9800 -17.0100
11 O2b O 15.5400 -15.1200
12 N2b N 21.0700 -17.7100
13 C1a C 17.4300 -14.2800
14 O5a O 19.8800 -14.2800
15 C1b C 13.7900 -16.3100
16 C1b C 14.1400 -15.1200
17 C1a C 12.5300 -17.0100
18 C1a C 13.4400 -13.9300
19 O3a O 19.8576 -18.4100
BOND 18
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 6 7 1
7 7 8 1
8 8 9 2
9 8 10 1
10 8 11 1
11 4 12 1
12 7 13 1
13 5 14 2
14 10 15 1
15 11 16 1
16 15 17 1
17 16 18 1
18 12 19 2
|
|---|
